Committee for Orphan Medicinal Products (COMP): 14-16 February 2017
Date:
14/02/2017 to 16/02/2017
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
COMP meeting report on the review of applications for orphan designation: February 2017 (PDF/202.26 KB)
First published: 27/02/2017
Last updated: 27/02/2017 -
List item
Agenda - COMP agenda of the 14-16 February 2017 meeting (PDF/240.35 KB)
Draft
First published: 14/02/2017
Last updated: 14/02/2017
EMA/COMP/50377/2017 -
List item
Minutes of the COMP meeting 14-16 February 2017 (PDF/312.34 KB)
Adopted
First published: 04/05/2017
Last updated: 04/05/2017
EMA/COMP/97842/2017